Specific serum protein biomarkers of rheumatoid arthritis detected by MALDI-TOF-MS combined with magnetic beads

International Immunology

Volumn 22, Issue 7, 2010, Pages 611-618

  Niu, Qian ^a   Huang, Zhuochun ^a   Shi, Yunying ^a   Wang, Lanlan ^a   Pan, Xiaofu ^a   Hu, Chaojun ^b  

^a SICHUAN UNIVERSITY   (China)

^b PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Autoimmune diseases; MALDI TOF MS; Proteomics; Rheumatoid arthritis; Weak cationic exchange magnetic beads

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CATION EXCHANGE; CLINICAL ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; DECISION TREE; DIAGNOSTIC ACCURACY; DISEASE MARKER; HUMAN; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEOMICS; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; BIOLOGICAL MARKERS; BLOOD PROTEINS; CHILD; FEMALE; HUMANS; MAGNETICS; MALE; MICROSPHERES; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; SJOGREN'S SYNDROME; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; YOUNG ADULT;

EID: 77954306674     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxq043     Document Type: Article

References (23)

1. Firestein, G. S. 2003. Evolving concepts of rheumatoid arthritis. Nature 423:356.
2. Turesson, C., Jacobsson, L. T., Sturefelt, G. et al. 2007. Rheumatoid factor and antibodies to cyclic citrullinated peptides are associated with severe exta-articular manifestations in rheumatoid arthritis. Ann. Rheum. Dis. 66:59.
3. Quinn, M. A., Gough, A. K. S., Green, M. J. et al. 2005. Anti-CCP antibodies measured at disease onset help identify seronegative rheumatoid arthritis and predict radiological and functional outcome. Rheumatology 45:478.
4. Howard, B. A., Wang, M. Z., Campa, M. J. et al. 2003. Identification and validation of a potential lung cancer serum biomarker detected by matrix-assisted laser desorption/ionizationtime of flight spectra analysis. Proteomics 3:720.
5. Cazares, L. H., Mitchell-Green, S., Leung, S.-M. et al. 2005. Serum protein expression patterns in head and neck cancer for biomarker discovery and identification using MALDI-TOF/TOF MS. AACR Meeting Abstracts, p. 1132.
6. TM technology, MALDI-TOF MS and, MALDI-TOF/TOF MS. AACR Meeting Abstracts, p. 1205. Bruker Daltonics, Billerica, MA.
7. Villanueva, J., Philip, J., Entenberg, D. et al. 2004. Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry. Anal. Chem. 76:1560.
8. Whiteaker, J. R., Zhao, L., Zhang, H. Y. et al. 2007. Antibodybased enrichment of peptides on magnetic beads for massspectrometry-based quantification of serum biomarkers. Anal. Biochem. 362:44.
9. Breiman, L., Friedman, J. H., Olshen, R. A. and Stone, C. J. 1984. Classification and Regression Trees. Wadsworth Publishing Co., Inc., Belmont, California.
10. Mei, J., Kolbin, D., Kao, H. T. and Porton, B. 2006. Protein expression profiling of postmortem brain in schizophrenia. Schizophr. Res. 84:204.
11. Bañez, L. L., Prasanna, P., Sun, L. et al. 2003. Diagnostic potential of serum proteomic patterns in prostate cancer. J. Urol. 170:442.
12. Banks, R. E., Dunn, M. J., Hochstrasser, D. F. et al. 2000. Proteomics: new perspectives, new biomedical opportunities. Lancet 356:1749.
13. Baumann, S., Ceglarek, U., Fiedler, G. M. et al. 2005. Standardized approach to proteome profiling of human serum based on magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin. Chem. 51:973.
14. Hawke, D., Mazouni, C., André, F. et al. 2009. Evaluation of serum profiles changes after neoadjuvant chemotherapy for breast cancer using MALDI-TOF/MS procedure. Tumor Biol. Hum. Genet. 27:e22072.
15. Kent Arrell, D., Neverova, I., Jennifer, E. et al. 2001. Cardiovascular proteomics: evolution and potential. Circ. Res. 88:763.
16. ópez-Pedrera, C. L., Barbarroja, N., Aguirre, M. A. et al. 2008. Genomics and proteomics: a new approach for assessing thrombotic risk in autoimmune diseases. Lupus 17:905.
17. Utz, P. J. 2004. Multiplexed assays for identification of biomarkers and surrogate markers in systemic lupus erythematosus. Lupus 13:304.
18. Ryu, O. H., Atkinson, J. C., Hoehn, G. T. et al. 2006. Identification of parotid salivary biomarkers in Sjögren's syndrome by surfaceenhanced laser desorption/ionization time-of-flight mass spectrometry and two-dimensional difference gel electrophoresis. Rheumatology 45:1077.
19. Doherty, N. S., Littman, B. H., Reilly, K. et al. 1998. Analysis of changes in acute-phase plasma proteins in an acute inflammatory response and in rheumatoid arthritis using two-dimensional gel electrophoresis. Electrophoresis 19:355.
20. Yamagiwa, H., Sarkar, G., Charlesworth, M. C. et al. 2003. Twodimensional gel electrophoresis of synovial fluid: method for detecting candidate protein markers for osteoarthritis. J. Orthop. Sci. 8:482.
21. Sinz, A., Bantscheff, M., Mikkat, S. et al. 2002. Mass spectrometric proteome analyses of synovial fluids and plasmas from patients suffering from rheumatoid arthritis and comparison to reactive arthritis or osteoarthritis. Electrophoresis 23:3445.
22. Drynda, S., Ringel, B., Kekow, M. et al. 2004. Proteome analysis reveals disease-associated marker proteins to differentiate RA patients from other inflammatory joint diseases with the potential to monitor anti-TNFalpha therapy. Pathol. Res. Pract. 200:165.
23. Dotzlaw, H., Schulz, M., Eggert, M. et al. 2004. A pattern of protein expression in peripheral blood mononuclear cells distinguishes rheumatoid arthritis patients from healthy individuals. Biochim. Biophys. Acta 1696:121.